Amir Lebastchi, MD
Urology · Los Angeles, CANPI 1972895142
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $402,090 of the $478,322 with a category attached, or 84.1%. EDAP Technomed Inc accounts for 88.3% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $191,476, more than ten times the $230 reported in 2021. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $1336.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EDAP Technomed Inc$422K
- Koelis Inc.$44K
- Angiodynamics, Inc.$10K
- Telix Pharmaceuticals$800
- Boston Scientific$280
- Teleflex LLC$263
- plus $1K from 13 others
Across 66 payments — averaging $2582.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$151K
- Angiodynamics, Inc.$20K
What the payments were for
- Consulting fees$402,09084%
- Speaking & faculty fees$8000%
- Travel & lodging$56,74812%
- Food & beverage$18,4334%
- Entertainment$2510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EDAP Technomed Inc | 262 | $422,492 |
| Koelis Inc. | 54 | $43,677 |
| Angiodynamics, Inc. | 15 | $9,702 |
| Telix Pharmaceuticals | 1 | $800 |
| Boston Scientific | 2 | $280 |
| Teleflex LLC | 4 | $263 |
| Myriad Genetic Laboratories, Inc. | 4 | $211 |
| Histosonics, Inc. | 2 | $190 |
| Medtronic | 2 | $155 |
| Dendreon Pharmaceuticals LLC | 1 | $152 |
| Progenics Pharmaceuticals, Inc. | 2 | $122 |
| 180 Medical, Inc. | 1 | $65 |
| AbbVie | 2 | $63 |
| Kairos Surgical Inc | 1 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Coloplast | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$478,322 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 69 | $458 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 15 | $141 |
| Finasteride | 21 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other urology in Los Angeles
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Stuart HoldenLos Angeles$1.1M
- William AronsonLos Angeles$540K
- Nazy ZomorodianLos Angeles$309K
- Jeffrey Loh-DoyleLos Angeles$308K
- Siamak DaneshmandLos Angeles$306K
- Karim ChamieLos Angeles$291K
- Brian ShuchLos Angeles$166K
- Robert ReiterLos Angeles$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.